These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5578738)

  • 21. The effect of antilymphocyte serum, imuran and hydrocortisone on the development of colibacillary infection in mice.
    Hatala M; Liska M; Hasková V; Gansová E
    Folia Biol (Praha); 1971; 17(4):264-6. PubMed ID: 4943669
    [No Abstract]   [Full Text] [Related]  

  • 22. Tumour development following immunosuppression.
    Allison AC
    Proc R Soc Med; 1970 Oct; 63(10):1077-80. PubMed ID: 4320709
    [No Abstract]   [Full Text] [Related]  

  • 23. [Response of lymph node cells to Freund's complete adjuvant and their growth-inhibition effect in experimental tumor (author's transl)].
    Seo Y; Furusawa M; Mashiba H; Horie A
    Nihon Gan Chiryo Gakkai Shi; 1978 Jun; 13(3):260-5. PubMed ID: 690496
    [No Abstract]   [Full Text] [Related]  

  • 24. Time relationships between injection of antigen and adjuvant. V. Primary and secondary immune responses to sheep erythrocytes in mice pretreated with incomplete freund's adjuvant.
    Finger H; Emmerling P; Hof H; Plager L
    Z Immunitatsforsch Exp Klin Immunol; 1973 May; 145(3):227-41. PubMed ID: 4283266
    [No Abstract]   [Full Text] [Related]  

  • 25. [Chronic antigenic stimulation as a pathogenic factor in the development of malignant lymphoma].
    Myking AO
    Nord Med; 1971 May; 85(21):645-9. PubMed ID: 5581410
    [No Abstract]   [Full Text] [Related]  

  • 26. [Significance of immunosuppression for the origin and growth of malignant tumors].
    Reis HE
    Dtsch Med Wochenschr; 1971 Jan; 96(4):170-4. PubMed ID: 4992740
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum lymphocyte cytotoxic titre responses in the mouse following injection of viable and dead human lymphocytes by varying routes and in differing doses, and the effect of Freund's adjuvant.
    Fox M; Gelsthorpe K; Doughty RW; Henry L
    Br J Surg; 1970 Nov; 57(11):849. PubMed ID: 4920296
    [No Abstract]   [Full Text] [Related]  

  • 28. [On the oncogenesia of plasmacytoma (LPC-1). Transplantable neoplasm (HIPA) with plasma cell evolution, induced by spleen homogenate from a BALB-c mouse treated with mineral oil. 1. Biology and histology].
    Pedio G; Grieshaber E; Rüttner JR
    Pathol Microbiol (Basel); 1968; 31(5):278-86. PubMed ID: 5687787
    [No Abstract]   [Full Text] [Related]  

  • 29. Specific removal of host-cell or vaccinia-virus antigens from extracts of infected cells by polyvalent disulphide-linked immunosorbents.
    Birkbeck TH; Stephen J
    J Gen Virol; 1970 Aug; 8(2):133-42. PubMed ID: 4097748
    [No Abstract]   [Full Text] [Related]  

  • 30. Plasmacytoma arising in giant lymph node hyperplasia.
    Schlosnagle DC; Chan WC; Hargreaves HK; Nolting SF; Brynes RK
    Am J Clin Pathol; 1982 Oct; 78(4):541-4. PubMed ID: 7137088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of skin resistance to vaccinia virus in rabbits by vaccinia-soluble early antigens.
    Ueda Y; Tagaya I
    J Exp Med; 1973 Nov; 138(5):1033-43. PubMed ID: 4744920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of mechanisms of action of anti-tumour factors made from lymph nodes or spleens of allergized allogeneic mice.
    Fraser LB; Cater DB
    Br J Exp Pathol; 1974 Aug; 55(4):328-35. PubMed ID: 4215442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphogenesis of two immunologically induced mouse lymphomas.
    Krueger GR; Heine UI
    Cancer Res; 1972 Mar; 32(3):573-82. PubMed ID: 4621957
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experimental plasmacytoma].
    Uda S
    Nihon Rinsho; 1972 Jan; 30(1):472-6. PubMed ID: 4556887
    [No Abstract]   [Full Text] [Related]  

  • 35. Neoplasia in kidney transplant recipients.
    Sterioff S; Rios CN; Zachary JB; Williams GM
    Am J Surg; 1975 Nov; 130(5):622-6. PubMed ID: 173202
    [No Abstract]   [Full Text] [Related]  

  • 36. Complications of immunosuppression.
    Penn I
    Minerva Chir; 1971 Jul; 26(13):718-20. PubMed ID: 5567243
    [No Abstract]   [Full Text] [Related]  

  • 37. Loss of protective activity of BALB-c spleen homogenate against cell-free transmission of HIPA-plasmacytoma by pretreatment with mineral oil of spleen-donor mice.
    Pedio G; Rüttner JR; Odermatt BF
    Pathol Microbiol (Basel); 1972; 38(5):375-8. PubMed ID: 4648589
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of antilymphocyte serum on the induction of neoplasms of lymphoreticular tissues.
    Law LW
    Fed Proc; 1970; 29(1):171-4. PubMed ID: 4312738
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of antilymphocyte serum. Personal experience and general remarks.
    Végh P; Petri G
    Panminerva Med; 1978; 20(1):39-47. PubMed ID: 347359
    [No Abstract]   [Full Text] [Related]  

  • 40. Kinetic studies of macrophages. V. Effect of antigen and adjuvant stimulation.
    Gillette RW; Swanson MH
    J Reticuloendothel Soc; 1974 Jan; 15(1):31-40. PubMed ID: 4810599
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.